Recent Trials

Argentina

Alecardio
Spire I & II

Alecardio

Effect Of Aleglitazar On Cardiovascular Outcomes After Acute Coronary Syndrome With Type 2 Diabetes Mellitus.

Study Metrics

Sites Initiated

32

Sites Randomized

25

Patients Screened

175

Patients Randomized

154

Previous Experience in Argentina

Other Trials

Cardiology

0
Trials
0
Sites Enrolled
0
Patients Enrolled

Oncology

0
Trials
0
Sites Enrolled
0
Patients Enrolled

Infectious Disease

0
Trials
0
Sites Enrolled
0
Patients Enrolled

CNS

0
Trials
0
Sites Enrolled
0
Patients Enrolled

Trials in Other Countries

Brazil - Colombia - Mexico

Brazil

Trials

Colombia

Trials

Mexico

Trials

Interested in Latin America?

Request a free consultation with our regional experts